Pediatric tuina in treating recurrent respiratory tract infection in children: a systematic review and meta‑analysis

Abstract

Review question / Objective: Is pediatric tuina an effective treatment for recurrent respiratory tract infection in children? Condition being studied: Recurrent respiratory tract infection (RRTI) is a common disease in children, which refers to the recurrence of upper and lower respiratory tract infections within a year, exceeding the prescribed number of times. It is more common in infants under 3 years old. The disease is easy to relapse and lasts for a long time, affecting the normal growth and development of children and physical and mental health, easily causing other diseases, leading to a variety of chronic wasting diseases, and damaging the function of organs and the immune system. Immunotherapy and nutritional therapy are commonly used in Western medicine. At present, the treatment of RRTI in children with traditional Chinese medicine has achieved a certain effect, and the treatment mainly includes internal treatment and external treatment. Tuina therapy is one of the common therapies for the treatment of RRTI in children with traditional Chinese medicine. Because of its advantages, there are many literature reports on tuina treatment of this disease, with a good total effective rate, but whether its therapeutic effect is higher than other therapies has not been determined as a whole. This study used the method of systematic review to collect the published clinical research literature on the treatment of RRTI in children at home and abroad for systematic review, so as to provide a reference for clinical research.